Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury

This study characterized the proinflammatory cytokines, interleukin-2 (IL-2) and tumor necrosis factor alpha (TNFalpha), the antiinflammatory cytokines, IL-4 and IL-10, autoantibodies specific for GM1 ganglioside (anti-GM1), IgG and IgM, and myelin-associated glycoprotein (anti-MAG), in the sera of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurotrauma 2002-06, Vol.19 (6), p.753-761
Hauptverfasser: HAYES, K. C, HULL, T. C. L, DELANEY, G. A, POTTER, P. J, SEQUEIRA, K. A. J, CAMPBELL, K, POPOVICH, P. G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 761
container_issue 6
container_start_page 753
container_title Journal of neurotrauma
container_volume 19
creator HAYES, K. C
HULL, T. C. L
DELANEY, G. A
POTTER, P. J
SEQUEIRA, K. A. J
CAMPBELL, K
POPOVICH, P. G
description This study characterized the proinflammatory cytokines, interleukin-2 (IL-2) and tumor necrosis factor alpha (TNFalpha), the antiinflammatory cytokines, IL-4 and IL-10, autoantibodies specific for GM1 ganglioside (anti-GM1), IgG and IgM, and myelin-associated glycoprotein (anti-MAG), in the sera of infection-free, chronic (>12 months), traumatically injured SCI patients (n = 24). Healthy able-bodied subjects (n = 26) served as controls. The proinflammatory cytokines and anti-GM1 antibodies were of particular interest as they have been implicated in an autoimmune "channelopathy" component to central and peripheral conduction deficits in various chronic neuroinflammatory diseases. Antibody and cytokine titers were established using enzyme-linked immunosorbent assays (ELISA). The mean anti-GM(1) (IgM) titer value for the SCI group was significantly higher (p < 0.05) than controls. The SCI group also demonstrated significantly higher titers (p < 0.05) of IL-2 and TNF alpha than controls. No differences were found between the SCI group and control group mean levels of IL-4 or IL-10. Overall, the serum of 57% of SCI patients contained increased levels of autoantibodies or proinflammatory cytokines relative to control values. These results provide preliminary support for the hypothesis that chronic immunological activation in the periphery occurs in a subpopulation of chronic SCI patients. It remains to be established whether elevated serum titers of proinflammatory cytokines and autoantibodies against GM1 are beneficial to the patients or whether they are surrogate markers of a channelopathy that compounds the neurological impairment associated with traumatic axonopathy or myelinopathy.
doi_str_mv 10.1089/08977150260139129
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71999477</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1149810351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-2a67476bcb795fab8cbf1d9d6ab24d46043253d6483e84a35c0b17f61eb4bef33</originalsourceid><addsrcrecordid>eNpl0UtrVDEYBuAgFjtWf4AbCYLuTs09c5Yy1AsUu6iuD19uNOM5yZjkVObfm9KBgi5CIHm-l4QXoTeUXFKyHT_2pTWVhClC-UjZ-AxtqJR6GIlgz9Hm4X7ogJ6jl7XuSVeK6RfonDKqJOVyg9ar2d9D8w5XX9YFt9h8qTgHfCg5pjDDskDL5YjtseVfMfmKITm8-36LYW0ZUosmu9iPY8IHaNGnVvGf2O6wvSs5RYvrISaYsc3FdbRfy_EVOgswV__6tF-gn5-vfuy-Dtc3X77tPl0PlkvRBgZKC62MNXqUAczWmkDd6BQYJpxQRHAmuVNiy_1WAJeWGKqDot4I4wPnF-jDY27_zO_V1zYtsVo_z5B8Xuuk6TiOQusO3_0D93kt_dV1YkRIIoWUHdFHZEuutfgwHUpcoBwnSqaHQqb_Cukzb0_Bq1m8e5o4NdDB-xOAamEOBZKN9clxrXoi538Bbe6URQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204505455</pqid></control><display><type>article</type><title>Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury</title><source>MEDLINE</source><source>Mary Ann Liebert</source><creator>HAYES, K. C ; HULL, T. C. L ; DELANEY, G. A ; POTTER, P. J ; SEQUEIRA, K. A. J ; CAMPBELL, K ; POPOVICH, P. G</creator><creatorcontrib>HAYES, K. C ; HULL, T. C. L ; DELANEY, G. A ; POTTER, P. J ; SEQUEIRA, K. A. J ; CAMPBELL, K ; POPOVICH, P. G</creatorcontrib><description>This study characterized the proinflammatory cytokines, interleukin-2 (IL-2) and tumor necrosis factor alpha (TNFalpha), the antiinflammatory cytokines, IL-4 and IL-10, autoantibodies specific for GM1 ganglioside (anti-GM1), IgG and IgM, and myelin-associated glycoprotein (anti-MAG), in the sera of infection-free, chronic (&gt;12 months), traumatically injured SCI patients (n = 24). Healthy able-bodied subjects (n = 26) served as controls. The proinflammatory cytokines and anti-GM1 antibodies were of particular interest as they have been implicated in an autoimmune "channelopathy" component to central and peripheral conduction deficits in various chronic neuroinflammatory diseases. Antibody and cytokine titers were established using enzyme-linked immunosorbent assays (ELISA). The mean anti-GM(1) (IgM) titer value for the SCI group was significantly higher (p &lt; 0.05) than controls. The SCI group also demonstrated significantly higher titers (p &lt; 0.05) of IL-2 and TNF alpha than controls. No differences were found between the SCI group and control group mean levels of IL-4 or IL-10. Overall, the serum of 57% of SCI patients contained increased levels of autoantibodies or proinflammatory cytokines relative to control values. These results provide preliminary support for the hypothesis that chronic immunological activation in the periphery occurs in a subpopulation of chronic SCI patients. It remains to be established whether elevated serum titers of proinflammatory cytokines and autoantibodies against GM1 are beneficial to the patients or whether they are surrogate markers of a channelopathy that compounds the neurological impairment associated with traumatic axonopathy or myelinopathy.</description><identifier>ISSN: 0897-7151</identifier><identifier>EISSN: 1557-9042</identifier><identifier>DOI: 10.1089/08977150260139129</identifier><identifier>PMID: 12165135</identifier><identifier>CODEN: JNEUE4</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>Adult ; Anticoagulants ; Autoantibodies - blood ; B-Lymphocytes - immunology ; Biological and medical sciences ; Chronic Disease ; Cytokines ; Enzymes ; Female ; G(M1) Ganglioside - immunology ; Glycoproteins ; Health care ; Humans ; Immunology ; Infections ; Injuries of the nervous system and the skull. Diseases due to physical agents ; Interleukin-10 - blood ; Interleukin-2 - blood ; Interleukin-4 - blood ; Male ; Medical laboratories ; Medical sciences ; Middle Aged ; Myelin-Associated Glycoprotein - immunology ; Spinal cord injuries ; Spinal Cord Injuries - blood ; Spinal Cord Injuries - immunology ; Trauma ; Traumas. Diseases due to physical agents ; Tumor Necrosis Factor-alpha - metabolism ; Tumor necrosis factor-TNF</subject><ispartof>Journal of neurotrauma, 2002-06, Vol.19 (6), p.753-761</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Mary Ann Liebert Inc. Jun 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-2a67476bcb795fab8cbf1d9d6ab24d46043253d6483e84a35c0b17f61eb4bef33</citedby><cites>FETCH-LOGICAL-c354t-2a67476bcb795fab8cbf1d9d6ab24d46043253d6483e84a35c0b17f61eb4bef33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3029,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13767153$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12165135$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HAYES, K. C</creatorcontrib><creatorcontrib>HULL, T. C. L</creatorcontrib><creatorcontrib>DELANEY, G. A</creatorcontrib><creatorcontrib>POTTER, P. J</creatorcontrib><creatorcontrib>SEQUEIRA, K. A. J</creatorcontrib><creatorcontrib>CAMPBELL, K</creatorcontrib><creatorcontrib>POPOVICH, P. G</creatorcontrib><title>Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury</title><title>Journal of neurotrauma</title><addtitle>J Neurotrauma</addtitle><description>This study characterized the proinflammatory cytokines, interleukin-2 (IL-2) and tumor necrosis factor alpha (TNFalpha), the antiinflammatory cytokines, IL-4 and IL-10, autoantibodies specific for GM1 ganglioside (anti-GM1), IgG and IgM, and myelin-associated glycoprotein (anti-MAG), in the sera of infection-free, chronic (&gt;12 months), traumatically injured SCI patients (n = 24). Healthy able-bodied subjects (n = 26) served as controls. The proinflammatory cytokines and anti-GM1 antibodies were of particular interest as they have been implicated in an autoimmune "channelopathy" component to central and peripheral conduction deficits in various chronic neuroinflammatory diseases. Antibody and cytokine titers were established using enzyme-linked immunosorbent assays (ELISA). The mean anti-GM(1) (IgM) titer value for the SCI group was significantly higher (p &lt; 0.05) than controls. The SCI group also demonstrated significantly higher titers (p &lt; 0.05) of IL-2 and TNF alpha than controls. No differences were found between the SCI group and control group mean levels of IL-4 or IL-10. Overall, the serum of 57% of SCI patients contained increased levels of autoantibodies or proinflammatory cytokines relative to control values. These results provide preliminary support for the hypothesis that chronic immunological activation in the periphery occurs in a subpopulation of chronic SCI patients. It remains to be established whether elevated serum titers of proinflammatory cytokines and autoantibodies against GM1 are beneficial to the patients or whether they are surrogate markers of a channelopathy that compounds the neurological impairment associated with traumatic axonopathy or myelinopathy.</description><subject>Adult</subject><subject>Anticoagulants</subject><subject>Autoantibodies - blood</subject><subject>B-Lymphocytes - immunology</subject><subject>Biological and medical sciences</subject><subject>Chronic Disease</subject><subject>Cytokines</subject><subject>Enzymes</subject><subject>Female</subject><subject>G(M1) Ganglioside - immunology</subject><subject>Glycoproteins</subject><subject>Health care</subject><subject>Humans</subject><subject>Immunology</subject><subject>Infections</subject><subject>Injuries of the nervous system and the skull. Diseases due to physical agents</subject><subject>Interleukin-10 - blood</subject><subject>Interleukin-2 - blood</subject><subject>Interleukin-4 - blood</subject><subject>Male</subject><subject>Medical laboratories</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myelin-Associated Glycoprotein - immunology</subject><subject>Spinal cord injuries</subject><subject>Spinal Cord Injuries - blood</subject><subject>Spinal Cord Injuries - immunology</subject><subject>Trauma</subject><subject>Traumas. Diseases due to physical agents</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Tumor necrosis factor-TNF</subject><issn>0897-7151</issn><issn>1557-9042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpl0UtrVDEYBuAgFjtWf4AbCYLuTs09c5Yy1AsUu6iuD19uNOM5yZjkVObfm9KBgi5CIHm-l4QXoTeUXFKyHT_2pTWVhClC-UjZ-AxtqJR6GIlgz9Hm4X7ogJ6jl7XuSVeK6RfonDKqJOVyg9ar2d9D8w5XX9YFt9h8qTgHfCg5pjDDskDL5YjtseVfMfmKITm8-36LYW0ZUosmu9iPY8IHaNGnVvGf2O6wvSs5RYvrISaYsc3FdbRfy_EVOgswV__6tF-gn5-vfuy-Dtc3X77tPl0PlkvRBgZKC62MNXqUAczWmkDd6BQYJpxQRHAmuVNiy_1WAJeWGKqDot4I4wPnF-jDY27_zO_V1zYtsVo_z5B8Xuuk6TiOQusO3_0D93kt_dV1YkRIIoWUHdFHZEuutfgwHUpcoBwnSqaHQqb_Cukzb0_Bq1m8e5o4NdDB-xOAamEOBZKN9clxrXoi538Bbe6URQ</recordid><startdate>20020601</startdate><enddate>20020601</enddate><creator>HAYES, K. C</creator><creator>HULL, T. C. L</creator><creator>DELANEY, G. A</creator><creator>POTTER, P. J</creator><creator>SEQUEIRA, K. A. J</creator><creator>CAMPBELL, K</creator><creator>POPOVICH, P. G</creator><general>Liebert</general><general>Mary Ann Liebert, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20020601</creationdate><title>Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury</title><author>HAYES, K. C ; HULL, T. C. L ; DELANEY, G. A ; POTTER, P. J ; SEQUEIRA, K. A. J ; CAMPBELL, K ; POPOVICH, P. G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-2a67476bcb795fab8cbf1d9d6ab24d46043253d6483e84a35c0b17f61eb4bef33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Anticoagulants</topic><topic>Autoantibodies - blood</topic><topic>B-Lymphocytes - immunology</topic><topic>Biological and medical sciences</topic><topic>Chronic Disease</topic><topic>Cytokines</topic><topic>Enzymes</topic><topic>Female</topic><topic>G(M1) Ganglioside - immunology</topic><topic>Glycoproteins</topic><topic>Health care</topic><topic>Humans</topic><topic>Immunology</topic><topic>Infections</topic><topic>Injuries of the nervous system and the skull. Diseases due to physical agents</topic><topic>Interleukin-10 - blood</topic><topic>Interleukin-2 - blood</topic><topic>Interleukin-4 - blood</topic><topic>Male</topic><topic>Medical laboratories</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myelin-Associated Glycoprotein - immunology</topic><topic>Spinal cord injuries</topic><topic>Spinal Cord Injuries - blood</topic><topic>Spinal Cord Injuries - immunology</topic><topic>Trauma</topic><topic>Traumas. Diseases due to physical agents</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HAYES, K. C</creatorcontrib><creatorcontrib>HULL, T. C. L</creatorcontrib><creatorcontrib>DELANEY, G. A</creatorcontrib><creatorcontrib>POTTER, P. J</creatorcontrib><creatorcontrib>SEQUEIRA, K. A. J</creatorcontrib><creatorcontrib>CAMPBELL, K</creatorcontrib><creatorcontrib>POPOVICH, P. G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurotrauma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HAYES, K. C</au><au>HULL, T. C. L</au><au>DELANEY, G. A</au><au>POTTER, P. J</au><au>SEQUEIRA, K. A. J</au><au>CAMPBELL, K</au><au>POPOVICH, P. G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury</atitle><jtitle>Journal of neurotrauma</jtitle><addtitle>J Neurotrauma</addtitle><date>2002-06-01</date><risdate>2002</risdate><volume>19</volume><issue>6</issue><spage>753</spage><epage>761</epage><pages>753-761</pages><issn>0897-7151</issn><eissn>1557-9042</eissn><coden>JNEUE4</coden><abstract>This study characterized the proinflammatory cytokines, interleukin-2 (IL-2) and tumor necrosis factor alpha (TNFalpha), the antiinflammatory cytokines, IL-4 and IL-10, autoantibodies specific for GM1 ganglioside (anti-GM1), IgG and IgM, and myelin-associated glycoprotein (anti-MAG), in the sera of infection-free, chronic (&gt;12 months), traumatically injured SCI patients (n = 24). Healthy able-bodied subjects (n = 26) served as controls. The proinflammatory cytokines and anti-GM1 antibodies were of particular interest as they have been implicated in an autoimmune "channelopathy" component to central and peripheral conduction deficits in various chronic neuroinflammatory diseases. Antibody and cytokine titers were established using enzyme-linked immunosorbent assays (ELISA). The mean anti-GM(1) (IgM) titer value for the SCI group was significantly higher (p &lt; 0.05) than controls. The SCI group also demonstrated significantly higher titers (p &lt; 0.05) of IL-2 and TNF alpha than controls. No differences were found between the SCI group and control group mean levels of IL-4 or IL-10. Overall, the serum of 57% of SCI patients contained increased levels of autoantibodies or proinflammatory cytokines relative to control values. These results provide preliminary support for the hypothesis that chronic immunological activation in the periphery occurs in a subpopulation of chronic SCI patients. It remains to be established whether elevated serum titers of proinflammatory cytokines and autoantibodies against GM1 are beneficial to the patients or whether they are surrogate markers of a channelopathy that compounds the neurological impairment associated with traumatic axonopathy or myelinopathy.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>12165135</pmid><doi>10.1089/08977150260139129</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0897-7151
ispartof Journal of neurotrauma, 2002-06, Vol.19 (6), p.753-761
issn 0897-7151
1557-9042
language eng
recordid cdi_proquest_miscellaneous_71999477
source MEDLINE; Mary Ann Liebert
subjects Adult
Anticoagulants
Autoantibodies - blood
B-Lymphocytes - immunology
Biological and medical sciences
Chronic Disease
Cytokines
Enzymes
Female
G(M1) Ganglioside - immunology
Glycoproteins
Health care
Humans
Immunology
Infections
Injuries of the nervous system and the skull. Diseases due to physical agents
Interleukin-10 - blood
Interleukin-2 - blood
Interleukin-4 - blood
Male
Medical laboratories
Medical sciences
Middle Aged
Myelin-Associated Glycoprotein - immunology
Spinal cord injuries
Spinal Cord Injuries - blood
Spinal Cord Injuries - immunology
Trauma
Traumas. Diseases due to physical agents
Tumor Necrosis Factor-alpha - metabolism
Tumor necrosis factor-TNF
title Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T18%3A12%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20serum%20titers%20of%20proinflammatory%20cytokines%20and%20CNS%20autoantibodies%20in%20patients%20with%20chronic%20spinal%20cord%20injury&rft.jtitle=Journal%20of%20neurotrauma&rft.au=HAYES,%20K.%20C&rft.date=2002-06-01&rft.volume=19&rft.issue=6&rft.spage=753&rft.epage=761&rft.pages=753-761&rft.issn=0897-7151&rft.eissn=1557-9042&rft.coden=JNEUE4&rft_id=info:doi/10.1089/08977150260139129&rft_dat=%3Cproquest_cross%3E1149810351%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204505455&rft_id=info:pmid/12165135&rfr_iscdi=true